These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6733812)

  • 1. Properties of cyclodextrin polymer as a tabletting aid.
    Fenyvesi E; Shirakura O; Szejtli J; Nagai T
    Chem Pharm Bull (Tokyo); 1984 Feb; 32(2):665-9. PubMed ID: 6733812
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of cyclodextrin polymer as an additive for furosemide tablet.
    Fenyvesi E; Takayama K; Szejtli J; Nagai T
    Chem Pharm Bull (Tokyo); 1984 Feb; 32(2):670-7. PubMed ID: 6733813
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclodextrin polymer, a new tablet disintegrating agent.
    Fenyvest E; Antal B; Zsadon B; Szejtli J
    Pharmazie; 1984 Jul; 39(7):473-5. PubMed ID: 6494226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular cavity filling and tabletting with beta-cyclodextrin].
    Hüttenrauch R; Fricke S
    Pharmazie; 1985 May; 40(5):361-2. PubMed ID: 4034643
    [No Abstract]   [Full Text] [Related]  

  • 5. The investigation of cyclodextrin polymer as a new disintegrant for direct compressed tablets.
    Sekulović D; Zajić L
    Pharmazie; 1987 Aug; 42(8):556. PubMed ID: 3432343
    [No Abstract]   [Full Text] [Related]  

  • 6. [Beta-cyclodextrin as an auxiliary substance in tabletting (preliminary communication)].
    Krajnyák J; Rácz I; Dávid A; Szejtli J
    Acta Pharm Hung; 1984 Mar; 54(2):90-1. PubMed ID: 6730980
    [No Abstract]   [Full Text] [Related]  

  • 7. Preparation and investigation of hydrochlorothiazide products containing beta-cyclodextrin.
    Kata M; Lukács M
    Pharmazie; 1984 Dec; 39(12):857-8. PubMed ID: 6531397
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on cyclodextrin polymer. Part 1: The effect of CDP on indomethacin tablet formulation.
    Tarimci N; Celebi N
    Pharmazie; 1988 May; 43(5):323-5. PubMed ID: 3174808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Application of beta-cyclodextrin during direct pressing of tablets].
    Szabóné RP; Pintyéné HK; Kun L; Miseta M; Selmeczi B
    Acta Pharm Hung; 1989 May; 59(3):99-107. PubMed ID: 2763849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amorphous water-soluble derivatives of cyclodextrins: nontoxic dissolution enhancing excipients.
    Pitha J; Pitha J
    J Pharm Sci; 1985 Sep; 74(9):987-90. PubMed ID: 4067854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential use of cyclodextrins in parenteral formulations.
    Brewster ME; Simpkins JW; Hora MS; Stern WC; Bodor N
    J Parenter Sci Technol; 1989; 43(5):231-40. PubMed ID: 2681643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production and investigating of tablets containing furosemide and beta-cyclodextrin.
    Kata M; Haragh L; Pintye-Hódi K
    Acta Pharm Hung; 1990 Jan; 60(1):40-5. PubMed ID: 2327256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Spray embedding of vinpocetin with beta-cyclodextrin].
    Kata M; György E
    Pharmazie; 1982 May; 37(5):386-7. PubMed ID: 7111372
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmaceutical applications of cyclodextrin complexations (author's transl)].
    Uekama K
    Yakugaku Zasshi; 1981 Oct; 101(10):857-73. PubMed ID: 7040632
    [No Abstract]   [Full Text] [Related]  

  • 15. In-line quantification of micronized drug and excipients in tablets by near infrared (NIR) spectroscopy: Real time monitoring of tabletting process.
    Karande AD; Heng PW; Liew CV
    Int J Pharm; 2010 Aug; 396(1-2):63-74. PubMed ID: 20558264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Stability test of chloramphenicol-beta-cyclodextrin-containing tablets].
    Szabó-Révész P; Pintye-Hódi K; Miseta M; Selmeczi B
    Pharmazie; 1988 Aug; 43(8):554-5. PubMed ID: 3237749
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of beta-cyclodextrin on the degradation rate of cinnarizine in aqueous solution.
    Tokumura T; Tatsuishi K; Kayano M; Machida Y; Nagai T
    Chem Pharm Bull (Tokyo); 1985 May; 33(5):2079-83. PubMed ID: 4053231
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclodextrin-stabilized volatile substances for inhalation therapy.
    Gál-Füzy M; Szente L; Szejtli J; Harangi J
    Pharmazie; 1984 Aug; 39(8):558-9. PubMed ID: 6504980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-cyclodextrin as a direct compression excipient compared to conventional ones.
    Saleh SI
    J Pharm Belg; 1993; 48(5):371-7. PubMed ID: 8120790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dextrin as excipient in pharmaceutical preparations.
    Lederer M; Leipzig-Paganini E
    Pharmazie; 2000 May; 55(5):378-9. PubMed ID: 11828620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.